DE3880092D1 - Antibiotika der mureidomycin-gruppe, deren herstellung und deren verwendung. - Google Patents

Antibiotika der mureidomycin-gruppe, deren herstellung und deren verwendung.

Info

Publication number
DE3880092D1
DE3880092D1 DE8888310822T DE3880092T DE3880092D1 DE 3880092 D1 DE3880092 D1 DE 3880092D1 DE 8888310822 T DE8888310822 T DE 8888310822T DE 3880092 T DE3880092 T DE 3880092T DE 3880092 D1 DE3880092 D1 DE 3880092D1
Authority
DE
Germany
Prior art keywords
group
carbon atoms
mureidomycin
antibiotics
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888310822T
Other languages
English (en)
Other versions
DE3880092T2 (de
Inventor
Tatsuo C O Sankyo Com Haneishi
Masatoshi C O Sankyo Co Inukai
Keiko C O Sankyo Compa Shimizu
Fujio C O Sankyo Company Isono
Yoshiharu C O Sankyo C Sakaida
Takeshi C O Sankyo C Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE3880092D1 publication Critical patent/DE3880092D1/de
Publication of DE3880092T2 publication Critical patent/DE3880092T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0217—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE88310822T 1987-11-20 1988-11-16 Antibiotika der Mureidomycin-Gruppe, deren Herstellung und deren Verwendung. Expired - Fee Related DE3880092T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29335287 1987-11-20
JP29335387 1987-11-20

Publications (2)

Publication Number Publication Date
DE3880092D1 true DE3880092D1 (de) 1993-05-13
DE3880092T2 DE3880092T2 (de) 1993-11-25

Family

ID=26559375

Family Applications (2)

Application Number Title Priority Date Filing Date
DE88310822T Expired - Fee Related DE3880092T2 (de) 1987-11-20 1988-11-16 Antibiotika der Mureidomycin-Gruppe, deren Herstellung und deren Verwendung.
DE3854205T Expired - Fee Related DE3854205T2 (de) 1987-11-20 1988-11-16 Zwischenprodukte der Mureidomycin-Gruppe, ihre Herstellung und Verwendung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3854205T Expired - Fee Related DE3854205T2 (de) 1987-11-20 1988-11-16 Zwischenprodukte der Mureidomycin-Gruppe, ihre Herstellung und Verwendung.

Country Status (8)

Country Link
US (1) US5041423A (de)
EP (2) EP0317292B1 (de)
KR (2) KR0137779B1 (de)
AT (1) ATE125256T1 (de)
CA (1) CA1339595C (de)
DE (2) DE3880092T2 (de)
ES (2) ES2054829T3 (de)
HK (2) HK1003573A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487756A1 (de) * 1990-11-26 1992-06-03 Hoechst Aktiengesellschaft Antibiotika-Napsamycin A-D, deren Herstellung und pharmazeutische Verwendung
US6228842B1 (en) 1998-11-06 2001-05-08 Microcide Pharmaceuticals, Inc. Pacidamycins produced by Streptomyces coeruleorubidus
US6482921B1 (en) * 1999-01-28 2002-11-19 Essential Therapeutics, Inc. Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use
CA2461951C (en) * 2001-09-27 2011-08-09 Biocon Limited Process for producing pravastatin sodium salt using streptomyces flavidovirens dsm 14455
KR102302414B1 (ko) 2014-06-20 2021-09-16 주식회사 만도 임피던스 저감을 위한 피씨비와 섀시간의 그라운드 결합구조

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3341571A1 (de) * 1983-11-17 1985-05-30 Bayer Ag, 5090 Leverkusen Neue antibiotika, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und zwischenprodukte zu ihrer herstellung
GB8421279D0 (en) * 1984-08-22 1984-09-26 Baldwin J E Antibiotics
IT1184164B (it) * 1985-03-19 1987-10-22 Eniricerche Spa Triptidi ad azione ipotensiva e procedimento per la loro sintesi
EP0253413B1 (de) * 1986-05-20 1993-10-13 Sankyo Company Limited Antibiotika "Mureidomycine A,B,C und D" genannt, deren Verfahren zur Herstellung und deren Verwendung

Also Published As

Publication number Publication date
ES2054829T3 (es) 1994-08-16
US5041423A (en) 1991-08-20
DE3854205T2 (de) 1996-04-04
DE3880092T2 (de) 1993-11-25
KR0137779B1 (ko) 1998-05-15
ATE125256T1 (de) 1995-08-15
ES2077345T3 (es) 1995-11-16
CA1339595C (en) 1997-12-23
EP0317292A2 (de) 1989-05-24
EP0517345A1 (de) 1992-12-09
DE3854205D1 (de) 1995-08-24
EP0517345B1 (de) 1995-07-19
HK1003573A1 (en) 1998-10-30
HK1005736A1 (en) 1999-01-22
KR0137675B1 (ko) 1998-05-15
KR890008130A (ko) 1989-07-08
EP0317292B1 (de) 1993-04-07
EP0317292A3 (en) 1990-07-25

Similar Documents

Publication Publication Date Title
ATE89822T1 (de) Durch benzhydryl n-substituierte heterocyclische derivate, ihre herstellung und ihre verwendung.
FI893467A0 (fi) Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
ATE161848T1 (de) Glycyrrheticsäurederivate
AU6572896A (en) Enantiomerically enriched thiazolidine or oxazolidine compounds
KR910021406A (ko) 축합 티아졸 화합물, 그의 제조 방법 및 용도
NO174848C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte
DE3880092D1 (de) Antibiotika der mureidomycin-gruppe, deren herstellung und deren verwendung.
CA1246583A (en) 4-ISOXAZOLYL)-THIAZOLE-2-OXAMIC ACIDS AND THEIR DERIVATIVES
FI875251A0 (fi) Foerfarande foer framstaellning av 2-arylpropionsyror.
IE891900L (en) Substituted 3-aminosydnone imines, a process for their¹preparation and their use
AU8591991A (en) Piperazine derivatives
ES2026548T3 (es) Un procedimiento para preparar penemos.
IT1222647B (it) Composti amminici stericamente impediti e procedimento per la loro preparazione

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee